ASX:ISXiSignthis Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding iSignthis Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Compare Share Today's Range N/A50-Day RangeA$0.79MA: A$0.99▼A$1.3652-Week Range N/AVolume20.04 million shsAverage VolumeN/AMarket Capitalization$1.17 billionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartCompetitorsInsider TradesHeadlines iSignthis Ltd, together with its subsidiaries, engages in remote identity verification, and payment authentication and processing activities in Australia, Europe, and British Virgin Islands. Its solutions include Paydentity, a solution that incorporates payment instrument verification and customer identification to remotely link an electronic payment with a person's identity for satisfying anti money laundering and counter terrorism financing regulatory requirements; and ISXPay, a solution, which provides a range of gateway, risk management and avoidance, and processing services for card transactions and alternative payment methods. iSignthis Ltd was founded in 2013 and is headquartered in Melbourne, Australia.Read More Beat the Market (BTM) Rank™ 2.0 Analyst's Opinion Price Target Upside/DownsideAccording to analysts' consensus price target of A$1.30, iSignthis has a potential upside of ∞ from its current price of A$0.00.Amount of Analyst CoverageiSignthis has received no research coverage in the past 90 days. Previous Next 3.3 Community Rank Outperform VotesiSignthis has received 28 “outperform” votes. (Add your “outperform” vote.)Underperform VotesiSignthis has received 15 “underperform” votes. (Add your “underperform” vote.)Community SentimentiSignthis has received 65.12% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about iSignthis and other stocks. Vote “Outperform” if you believe ISX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ISX will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldiSignthis does not currently pay a dividend.Dividend GrowthiSignthis does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, iSignthis insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of iSignthis is -178.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of iSignthis is -178.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next Analyst Opinion: 2.0Community Rank: 3.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.06 out of 5 stars Industry, Sector and Symbol Stock Exchange ASX Industry Software - Application Sub-IndustryN/A SectorComputer and Technology Current SymbolASX:ISX Previous Symbol CUSIPN/A CIKN/A Webwww.isignthis.com Phone61 3 8640 0990Debt Debt-to-Equity Ratio11.46 Current Ratio1.15 Quick Ratio0.18Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$31.24 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow102.78 Book ValueA$0.02 per share Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares1,095,449,984Market Cap$1.17 billion Next Earnings DateN/A OptionableNot Optionable Receive ISX News and Ratings via Email Sign-up to receive the latest news and ratings for ISX and its competitors with MarketBeat's FREE daily newsletter. iSignthis (ASX:ISX) Frequently Asked Questions Do Wall Street analysts recommend investors buy shares of iSignthis? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for iSignthis in the last year. There are currently 1 strong buy rating for the stock, resulting in a consensus recommendation of "Strong Buy." View analyst ratings for iSignthis. What price target have analysts set for ISX? 1 analysts have issued 12-month price objectives for iSignthis' shares. Their forecasts range from A$1.30 to A$1.30. On average, they anticipate iSignthis' stock price to reach A$1.30 in the next twelve months. View analysts' price targets for iSignthis. Has iSignthis been receiving favorable news coverage? Media stories about ISX stock have trended negative this week, according to InfoTrie Sentiment. InfoTrie identifies positive and negative media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. iSignthis earned a daily sentiment score of -2.6 on InfoTrie's scale. They also gave headlines about the company a news buzz of 9.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the near term. View the latest news aboutiSignthis. Who are some of iSignthis' key competitors? Some companies that are related to iSignthis include Altium (ALU), Kinaxis (KXS), Appen (APX), Technology One (TNE), Enghouse Systems (ENGH), Sophos Group (SOPH), Rocket Internet (RKET), Lightspeed POS (LSPD), Integrafin (IHP), Pushpay (PPH), Real Matters (REAL), RIB Software (RIB), Blue Prism Group (PRSM), Bravura Solutions (BVS) and Isra Vision (ISR). View all competitors. What other stocks do shareholders of iSignthis own? Based on aggregate information from My MarketBeat watchlists, some companies that other iSignthis investors own include Polynovo (PNV), Paradigm Biopharmaceuticals (PAR), Novo Resources (NVO), Nearmap (NEA), MGC Pharmaceuticals (MXC), Medlab Clinical (MDC), BOD Australia (BDA), Avita Medical (AVH), Alcidion Group (ALC) and Auscann Group (AC8). Who are iSignthis' key executives? iSignthis' management team includes the following people: Mr. Nickolas John Karantzis, MD, CEO & Exec. DirectorMr. Todd Richards B.Bus, CPA, CFO & Company Sec.Mr. Andrew Karantzis, Global Sales & Marketing Director What is iSignthis' stock symbol? iSignthis trades on the ASX under the ticker symbol "ISX." How big of a company is iSignthis? iSignthis has a market capitalization of $0.00 and generates $31.24 million in revenue each year. What is iSignthis' official website? The official website for iSignthis is www.isignthis.com. How can I contact iSignthis? The company can be reached via phone at 61 3 8640 0990. This page was last updated on 5/26/2020 by MarketBeat.com Staff
